Literature DB >> 20354856

A case report of systemic lupus erythematosus combined with Castleman's disease and literature review.

Jing-Yan Xia1, Xi-Yuan Chen, Feng Xu, Yan Yang, Hui-Ying Wang, Jing Xue.   

Abstract

Although lymph node enlargement is common in active systemic lupus erythematosus (SLE), lymph node examination is frequently ignored in the diagnosis of SLE. Clinical presentation and abnormal laboratory findings are often sufficient for SLE diagnosis, not to mention that the specific histological finding of lymph node necrosis in SLE is rarely seen, and the follicular hyperplasia is usually considered as nonspecific. However, since the late 1990s, a few cases of SLE lymphadenopathy have been reported exhibiting a Castleman's disease (CD) morphology, which was discovered in lymph node biopsies. Here we report a similar case of SLE combined with CD in a 23-year-old girl who displayed systemic symptoms, including systemic lymphadenopathy and abnormal laboratory findings indicating the active phase of SLE. A biopsy of neck lymphnodes showed histopathological features of CD. The patient responded very well to the prednisolone treatment. Based on the related literature review, we would like to stress the possibility of CD in patients with SLE lymphadenopathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20354856     DOI: 10.1007/s00296-010-1451-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  15 in total

1.  Autoimmune disease-associated lymphadenopathy with histological appearance of T-zone dysplasia with hyperplastic follicles. A clinicopathological analysis of nine cases.

Authors:  M Kojima; S Nakamura; T Oyama; T Motoori; H Itoh; K Yoshida; T Suchi; N Masawa
Journal:  Pathol Res Pract       Date:  2001       Impact factor: 3.250

2.  [Castleman disease of the neck].

Authors:  M D Cobzeanu; Danielu Rusu; D Negru; D Ferariu
Journal:  Rev Med Chir Soc Med Nat Iasi       Date:  2005 Jul-Sep

3.  Multicentric Castleman disease and systemic lupus erythematosus phenotype in a boy with Klinefelter syndrome: long-term disease stabilization with interferon therapy.

Authors:  R Simko; K Nagy; B Lombay; A Kiss; K Minik; V H Lukacs; I Vamosi
Journal:  J Pediatr Hematol Oncol       Date:  2000 Mar-Apr       Impact factor: 1.289

4.  Reactive hyperplasia with giant follicles in lymph node lesions from systemic lupus erythematosus patients. Report of three cases.

Authors:  M Kojima; H Matsuda; M Iijima; K Yoshida; N Masawa; S Nakamura
Journal:  APMIS       Date:  2005 Jul-Aug       Impact factor: 3.205

Review 5.  The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.

Authors:  W B Bowne; J J Lewis; D A Filippa; R Niesvizky; A D Brooks; M E Burt; M F Brennan
Journal:  Cancer       Date:  1999-02-01       Impact factor: 6.860

6.  A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.

Authors:  G Frizzera; B A Peterson; E D Bayrd; A Goldman
Journal:  J Clin Oncol       Date:  1985-09       Impact factor: 44.544

7.  Systemic lupus erythematosus (SLE) lymphadenopathy presenting with histopathologic features of Castleman' disease: a clinicopathologic study of five cases.

Authors:  M Kojima; S Nakamura; H Itoh; K Yoshida; S Asano; N Yamane; S Komatsumoto; S Ban; T Joshita; T Suchi
Journal:  Pathol Res Pract       Date:  1997       Impact factor: 3.250

8.  The clinical behavior of localized and multicentric Castleman disease.

Authors:  J Herrada; F Cabanillas; L Rice; J Manning; W Pugh
Journal:  Ann Intern Med       Date:  1998-04-15       Impact factor: 25.391

9.  Atypical lymphoplasmacytic and immunoblastic proliferation in lymph nodes of patients with autoimmune disease (autoimmune-disease-associated lymphadenopathy).

Authors:  C H Koo; B N Nathwani; C D Winberg; L R Hill; H Rappaport
Journal:  Medicine (Baltimore)       Date:  1984-09       Impact factor: 1.889

Review 10.  Autoimmune findings resembling connective tissue disease in a patient with Castleman's disease.

Authors:  F Gohlke; E Märker-Hermann; S Kanzler; M Mitze; K H Meyer zum Büschenfelde
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 3.650

View more
  1 in total

1.  Successful Treatment with Rituximab in a Patient with Castleman's Disease Complicated by Systemic Lupus Erythematosus and Severe Autoimmune Thrombocytopenia.

Authors:  Lu Zhang; Li Jiao; Shu-Jie Wang
Journal:  Chin Med J (Engl)       Date:  2015-09-20       Impact factor: 2.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.